Related references
Note: Only part of the references are listed.Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment
Christel J. M. de Blok et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen
Luuk J. J. Scheres et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen
Rosa Fernandez et al.
JOURNAL OF SEXUAL MEDICINE (2020)
Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones
Sebastian E. E. Schagen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria
Tessa Brik et al.
ARCHIVES OF SEXUAL BEHAVIOR (2020)
Cardiovascular Disease Risk Factors and Myocardial Infarction in the Transgender Population
Talal Alzahrani et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2019)
Cardiovascular implications of gender-affirming hormone treatment in the transgender population
Erika Dutra et al.
MATURITAS (2019)
Endocrinology of Transgender Medicine
Guy T'Sjoen et al.
ENDOCRINE REVIEWS (2019)
Effects of sex steroids on cardiovascular risk profile in transgender men under gender affirming hormone therapy
Gloria Aranda et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2019)
Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study
M. Klaver et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
Ilaria Mancini et al.
GYNECOLOGICAL ENDOCRINOLOGY (2018)
Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study
Christel Josefa Maria de Blok et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Gender Identity, Hormone Therapy, and Cardiovascular Disease Risk
Claudia Martinez et al.
CURRENT PROBLEMS IN CARDIOLOGY (2018)
Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis
Damon E. Houghton et al.
THROMBOSIS RESEARCH (2018)
Health and Cardiometabolic Disease in Transgender Adults in the United States: Behavioral Risk Factor Surveillance System 2015
Natalie J. Nokoff et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis
M. Klaver et al.
ANDROLOGIA (2017)
Perceptual analysis of the male-to-female transgender voice after glottoplastythe telephone test
Jonas Meister et al.
LARYNGOSCOPE (2017)
Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients
Daniel I. Spratt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis
Spyridoula Maraka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline
Wylie C. Hembree et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment
Gloria Aranda et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Self-perception of voice in transgender persons during cross-sex hormone therapy
Charlotte Bultynck et al.
LARYNGOSCOPE (2017)
Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review
I. Velho et al.
ANDROLOGY (2017)
Transgender hormone therapy: understanding international variation in practice
Yaasir Mamoojee et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Testosterone therapy for transgender men
Michael S. Irwig
LANCET DIABETES & ENDOCRINOLOGY (2017)
Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment
Justine Defreyne et al.
LGBT HEALTH (2017)
Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
O. M. Moreno-Arrones et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Lifetime Risk of Venous Thromboembolism in Two Cohort Studies
Elizabeth J. Bell et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness
Giulia Gava et al.
CLINICAL ENDOCRINOLOGY (2016)
Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data
Alessandra D. Fisher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
A European Network for the Investigation of Gender Incongruence: Endocrine Part
M. J. H. J. Dekker et al.
JOURNAL OF SEXUAL MEDICINE (2016)
Effects of Cross-Sex Hormone Treatment on Transgender Women and Men
Madeline B. Deutsch et al.
OBSTETRICS AND GYNECOLOGY (2015)
Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals
Jamie D. Weinand et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2015)
Voice and Communication Change for Gender Nonconforming Individuals: Giving Voice to the Person Inside
Shelagh Davies et al.
INTERNATIONAL JOURNAL OF TRANSGENDERISM (2015)
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review
H. Asscheman et al.
ANDROLOGIA (2014)
Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up: Results from the European Network for the Investigation of Gender Incongruence
Katrien Wierckx et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones
Katrien Wierckx et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons
Carla Pelusi et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Management of female- to- male transgender persons: medical and surgical management, life expectancy
Louis J. Gooren
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2014)
ENDOCRINE TREATMENT OF TRANSSEXUAL PERSONS: EXTENSIVE PERSONAL EXPERIENCE
Matthew C. Leinung et al.
ENDOCRINE PRACTICE (2013)
Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study
K. Wierckx et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens
L. J. Seal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Long-Term Evaluation of Cross-Sex Hormone Treatment in Transsexual Persons
Katrien Wierckx et al.
JOURNAL OF SEXUAL MEDICINE (2012)
Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study
Miguel Gil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones
Henk Asscheman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Care of Transsexual Persons
Louis J. Gooren
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden
Cecilia Dhejne et al.
PLOS ONE (2011)
Abrupt Regression of a Meningioma after Discontinuation of Cyproterone Treatment
A. M. G. Goncalves et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses
Mohamed B. Elamin et al.
CLINICAL ENDOCRINOLOGY (2010)
Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study
Michel K. Barsoum et al.
THROMBOSIS RESEARCH (2010)
Long-term treatment of transsexuals with cross-sex hormones: Extensive personal experience
Louis J. Gooren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals
EJ Giltay et al.
ATHEROSCLEROSIS (2003)
Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects
JMH Elbers et al.
CLINICAL ENDOCRINOLOGY (2003)
Oral ethinyl estradiol, but not transdermal 17β-estradiol, increases plasma C-reactive protein levels in men
EJ Giltay et al.
THROMBOSIS AND HAEMOSTASIS (2000)
Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis
EJ Giltay et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
